A continuous glucose monitor is a wearable device that measures blood glucose levels every five minutes, then reports back the information -- I see mine on my smartphone. CGMs can be as small as two ...

Valued at a market cap of $29.6 billion, San Diego, California-based DexCom, Inc. (DXCM) is a medical device company ...

This week Bobbi Conner talks with MUSC's Dr. Aundrea Loftley about using a continuous glucose monitor for diabetes management ...

CGMs are prescribed to diabetics to monitor their blood sugar. They're now available and becoming wildly popular for over-the ...

With an increasing burden of diabetes in Singapore, digital innovations, research can help diabetics manage better. Read more ...

Waiting on Apple to add glucose tracking on a smartwatch to learn about your blood sugar? Don't. Try a biosensor instead.

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

24 analysts are following DexCom and have set target prices ranging from $75.0 to $120.0 per share. On average, they have ...

Progressing the development of a novel CGM sensor to the point where it can improve the quality of life for millions of people with diabetes can be a tall order. In order to build confidence that the ...

We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at ...

Dexcom has rounded up its celebrity spokespeople for World Diabetes Day, putting singer Nick Jonas at the center of a ...

The University of Pittsburgh is studying ways to improve the lives of Type 2 diabetics, or people who just want to control their sugar levels.